在中度阿尔茨海默氏症痴呆症中对执行功能和注意力训练的传统和基于技术的方法进行比较
Jesus Gonzalez-Moreno1, Gema Soria-Urios2, Encarnacion Satorres2
1Universidad Internacional de Valencia (Spain)
Psicothema
|January 22, 2025
概括
传统的和基于技术的认知训练有效地改善了中度阿尔茨海默病患者的执行功能和注意力. 这些干预措施为管理认知衰退提供了实际的好处.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 认知心理学 认知心理学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病.
- 中度AD的特点是执行功能和注意力显著下降.
- 认知干预旨在减轻AD患者的认知缺陷.
研究的目的:
- 为了比较传统与基于技术的认知干预措施的有效性.
- 评估这些干预措施对执行职能和注意力的影响.
- 评估与中度阿尔茨海默氏症患者的对照组对结果的评估.
主要方法:
- 一项随机对照试验,涉及112名中度阿尔茨海默病患者.
- 三组:传统的认知干预,基于技术的认知干预和控制.
- 16次干预会议,使用标准化测试和层次线性混合模型进行评估.
主要成果:
- 这两种认知干预类型都显著改善了执行功能.
- 迷你心理状态考试 (MMSE) 的分数调整了后向数字和分类流利性任务的有效性.
- 高等教育水平和认知表现对相似性-抽象能力产生了积极的影响.
结论:
- 认知训练是一种有益的治疗工具,可以增强中度AD的执行功能和注意力.
- 干预措施在管理认知症状方面显示出实际价值.
- 未来的研究应该探索技能转移机制,以优化AD干预和患者生活质量.
相关概念视频
01:22Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
01:26Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439